Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.

[1]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[2]  E. Marbán,et al.  Mixed results for bone marrow–derived cell therapy for ischemic heart disease. , 2012, JAMA.

[3]  Joshua M Hare,et al.  Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. , 2012, JAMA.

[4]  Doris A Taylor,et al.  Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. , 2012, JAMA.

[5]  Dejian Lai,et al.  Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. , 2012, JAMA.

[6]  Kenneth R Chien,et al.  Towards regenerative therapy for cardiac disease , 2012, The Lancet.

[7]  Stephen F Badylak,et al.  RETRACTED: Engineered whole organs and complex tissues , 2012, The Lancet.

[8]  Daniel Berman,et al.  Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial , 2012, The Lancet.

[9]  K. Brunt,et al.  Stem cells and regenerative medicine - future perspectives. , 2012, Canadian journal of physiology and pharmacology.

[10]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[11]  Mark A Sussman,et al.  Empowering adult stem cells for myocardial regeneration. , 2011, Circulation research.

[12]  Marcus F Stoddard,et al.  Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial , 2011, The Lancet.

[13]  Doris A Taylor,et al.  Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. , 2011, JAMA.

[14]  E. Marbán,et al.  The Stuttering Progress of Cell Therapy for Heart Disease , 2011, Clinical pharmacology and therapeutics.

[15]  A. Terzic,et al.  Cardiovascular Health: The Global Challenge , 2011, Clinical pharmacology and therapeutics.

[16]  M. Penn,et al.  Stem Cells for Myocardial Regeneration , 2011, Clinical pharmacology and therapeutics.

[17]  V. Fuster,et al.  From Treating Complex Coronary Artery Disease to Promoting Cardiovascular Health: Therapeutic Transitions and Challenges, 2010–2020 , 2011, Clinical pharmacology and therapeutics.

[18]  J. Hare,et al.  Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. , 2011, Circulation research.

[19]  B. Strauer,et al.  10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. , 2011, Journal of the American College of Cardiology.

[20]  T. Henry,et al.  Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina , 2011, Circulation research.

[21]  A. Dietz,et al.  Platelet Lysate Consisting of a Natural Repair Proteome Supports Human Mesenchymal Stem Cell Proliferation and Chromosomal Stability , 2011, Cell transplantation.

[22]  M. Lythgoe,et al.  De novo cardiomyocytes from within the activated adult heart after injury , 2011, Nature.

[23]  A. Mathur,et al.  Stem cell therapy for heart diseases. , 2011, British medical bulletin.

[24]  A. Terzic,et al.  Chronic Diseases: The Emerging Pandemic , 2011, Clinical and translational science.

[25]  Peter A. Altman,et al.  Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy: Functional Recovery and Reverse Remodeling , 2011, Circulation research.

[26]  Michael D. Schneider,et al.  Cardiac muscle regeneration: lessons from development. , 2011, Genes & development.

[27]  P. Menasché.  Cardiac cell therapy: lessons from clinical trials. , 2011, Journal of molecular and cellular cardiology.

[28]  J. Epstein.  Franklin H. Epstein Lecture. Cardiac development and implications for heart disease. , 2010, The New England journal of medicine.

[29]  P. Pattany,et al.  Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation , 2010, Circulation research.

[30]  E. Marbán,et al.  Boot camp for mesenchymal stem cells. , 2010, Journal of the American College of Cardiology.

[31]  A. Terzic,et al.  Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. , 2010, Journal of the American College of Cardiology.

[32]  A. Mathur,et al.  Cardiac stem cell therapy: progress from the bench to bedside , 2010, Heart.

[33]  P. Goichberg,et al.  Cardiomyogenesis in the Adult Human Heart , 2010, Circulation research.

[34]  A. Terzic,et al.  Regenerative medicine advancing health care 2020. , 2010, Journal of the American College of Cardiology.

[35]  A. Terzic,et al.  Cells as biologics for cardiac repair in ischaemic heart failure , 2010, Heart.

[36]  C. Mummery,et al.  Challenges in Using Stem Cells for Cardiac Repair , 2010, Science Translational Medicine.

[37]  S. Gronthos,et al.  Intramyocardial Navigation and Mapping for Stem Cell Delivery , 2010, Journal of cardiovascular translational research.

[38]  H. Drexler,et al.  Cell therapy for the treatment of coronary heart disease: a critical appraisal , 2010, Nature Reviews Cardiology.

[39]  J. McMurray,et al.  Clinical practice. Systolic heart failure. , 2010, The New England journal of medicine.

[40]  E. Chavakis,et al.  Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back. , 2010, Circulation.

[41]  S. Janssens.  Stem cells in the treatment of heart disease. , 2010, Annual review of medicine.

[42]  Joshua M Hare,et al.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[43]  B. Gersh,et al.  Cardiac cell repair therapy: a clinical perspective. , 2009, Mayo Clinic proceedings.

[44]  F. Fernández‐Avilés,et al.  Delivery of Biologics in Cardiovascular Regenerative Medicine , 2009, Clinical pharmacology and therapeutics.

[45]  A. Terzic,et al.  Stem Cells: Biologics for Regeneration , 2008, Clinical pharmacology and therapeutics.

[46]  Samuel Bernard,et al.  Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.

[47]  D. K. Arrell,et al.  Guided stem cell cardiopoiesis: discovery and translation. , 2008, Journal of molecular and cellular cardiology.

[48]  N. Kröger,et al.  Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM , 2008, Bone Marrow Transplantation.

[49]  E. Jones,et al.  Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies , 2008, Mechanisms of Ageing and Development.

[50]  Richard T. Lee,et al.  Stem-cell therapy for cardiac disease , 2008, Nature.

[51]  A. Zeiher,et al.  Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.

[52]  A. Zeiher,et al.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. , 2006, The New England journal of medicine.

[53]  A. Terzic,et al.  Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny , 2006, Nature Clinical Practice Cardiovascular Medicine.

[54]  Karl Swedberg,et al.  Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients , 2005, Circulation.

[55]  T. Rector.  A conceptual model of quality of life in relation to heart failure. , 2005, Journal of cardiac failure.

[56]  Stefanie Dimmeler,et al.  Unchain my heart: the scientific foundations of cardiac repair. , 2005, The Journal of clinical investigation.

[57]  D. Kitzman,et al.  American Society of Echocardiography recommendations for use of echocardiography in clinical trials. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[58]  M. Packer,et al.  Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. , 2001, Journal of cardiac failure.

[59]  G. Lamas,et al.  Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. , 1997, Circulation.

[60]  A. Terzic,et al.  Brachial approach to NOGA-guided procedures: electromechanical mapping and transendocardial stem-cell injections. , 2011, Texas Heart Institute journal.